Zobrazeno 1 - 10
of 4 697
pro vyhledávání: '"Laat W"'
Autor:
Zaugg JB; European Molecular Biology Laboratory, Heidelberg, Germany., Sahlén P; Science for Life Laboratory, KTH - Royal Institute of Technology, Solna, Sweden., Andersson R; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Alberich-Jorda M; Department of Hemato-oncology, Institute of Molecular Genetics of the CAS, Prague, Czech Republic.; Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic., de Laat W; Hubrecht Institute-KNAW, Oncode Institute and University Medical Center Utrecht, Utrech, Netherlands., Deplancke B; Laboratory of Systems Biology and Genetics, Institute of Bio-engineering, School of Life Sciences, EPFL, Lausanne, Switzerland., Ferrer J; Centre for Genomic Regulation, the Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en red Diabetes y enfermedades metabólicas asociadas (CIBERDEM), Madrid, Spain.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Mandrup S; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Natoli G; IEO, European Institute of Oncology - IRCCS, Milan, Italy., Plewczynski D; Laboratory of Functional and Structural Genomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland., Rada-Iglesias A; Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/University of Cantabria, Santander, Spain., Spicuglia S; TAGC, UMR 1090, Aix-Marseille University, INSERM, Marseille, France. salvatore.spicuglia@inserm.fr.; Equipe Labellisée, LIGUE Contre le Cancer, Marseille, France. salvatore.spicuglia@inserm.fr.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2022 Dec; Vol. 29 (12), pp. 1148-1158. Date of Electronic Publication: 2022 Dec 08.
Autor:
Venema WJ; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hiddingh S; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Loosdregt J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Bowes J; Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Balliu B; Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., de Boer JH; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ossewaarde-van Norel J; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Thompson SD; Department of Pediatrics, University of Cincinnati College of Medicine, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Langefeld CD; Department of Biostatistics and Data Science, and Center for Precision Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., de Ligt A; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van der Veken LT; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Krijger PHL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands., de Laat W; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands., Kuiper JJW; Department of Ophthalmology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: j.j.w.kuiper@umcutrecht.nl.
Publikováno v:
Cell genomics [Cell Genom] 2024 Jan 10; Vol. 4 (1), pp. 100460. Date of Electronic Publication: 2023 Dec 05.
Autor:
Turek, Łukasz1 lukasz.turek@wszzkielce.pl, Sadowski, Marcin1, Janion-Sadowska, Agnieszka1, Kurzawski, Jacek1, Jaroszyński, Andrzej1
Publikováno v:
Medical Studies / Studia Medyczne. 2022, Vol. 38 Issue 2, p132-139. 8p.
Autor:
de Laat, W
Door veranderende wet- en regelgeving zal een deel van het uitzendwerk in de toekomst weinig tot geen bestaansrecht meer hebben. Uitzendorganisaties moeten transformeren naar nieuwe businessmodellen om concurrerend te blijven. Echter ligt de focus va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4301::7b47658310abbd656011141a1ad62f63
https://research.ou.nl/en/studentTheses/ea0806c3-32bf-4ebf-904f-132947fbe7e6
https://research.ou.nl/en/studentTheses/ea0806c3-32bf-4ebf-904f-132947fbe7e6
Autor:
de Laat W; LiGalli, The Hague, The Netherlands., Pagan L; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands., Malcolm RK; School of Pharmacy, Queen's University Belfast, United Kingdom., Wiegerinck M; LiGalli, The Hague, The Netherlands., Nickolson V; LiGalli, The Hague, The Netherlands., Huisman B; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands., Stuurman R; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., van Esdonk M; Centre for Human Drug Research, Leiden, The Netherlands., Klarenbeek N; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2180113.
Autor:
Stelloo E; Cergentis BV, Utrecht, the Netherlands., Meijers RWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Swennenhuis JF; Cergentis BV, Utrecht, the Netherlands., Allahyar A; Oncode Institute, Hubrecht Institute-Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht, Utrecht, the Netherlands., Hajo K; Cergentis BV, Utrecht, the Netherlands., Cangiano M; Cergentis BV, Utrecht, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., van Helvert S; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Van der Meulen J; Molecular Diagnostics, Ghent University Hospital, Ghent, Belgium., Creytens D; Department of Pathology, Ghent University Hospital, Ghent, Belgium., van Kempen LC; Department of Pathology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Laat W; Oncode Institute, Hubrecht Institute-Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands., Feitsma H; Cergentis BV, Utrecht, the Netherlands. Electronic address: harma.feitsma@cergentis.com.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Oct; Vol. 25 (10), pp. 758-770. Date of Electronic Publication: 2023 Jul 28.
Autor:
Rouillon C; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Eckhardt BV; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Kollenstart L; Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark., Gruss F; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Verkennis AEE; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Rondeel I; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Krijger PHL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Ricci G; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Biran A; Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark., van Laar T; Kavli Institute of Nanoscience Delft, TU Delft, The Netherlands., Delvaux de Fenffe CM; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Luppens G; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands., Albanese P; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands., Sato K; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Scheltema RA; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands., de Laat W; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Knipscheer P; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands., Dekker NH; Kavli Institute of Nanoscience Delft, TU Delft, The Netherlands., Groth A; Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark., Mattiroli F; Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2023 May 08; Vol. 51 (8), pp. 3770-3792.
Autor:
Smits WK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vermeulen C; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Hagelaar R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Kimura S; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., Vroegindeweij EM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs-Gladdines JGCAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van de Geer E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands., van Reijmersdal SV; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs A; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Galjart N; Department of Cell Biology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Eyndhoven W; Diagnostics and Genomics Group, Agilent Technologies, Amstelveen, the Netherlands., van Min M; Cergentis BV, Utrecht, the Netherlands., Kuiper R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mullighan CG; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., de Laat W; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: jules.meijerink@acerta-pharma.com.
Publikováno v:
Cell reports [Cell Rep] 2023 Apr 25; Vol. 42 (4), pp. 112373. Date of Electronic Publication: 2023 Apr 14.
Autor:
Huang Y; Oncode Institute, Hubrecht Institute-KNAW, University Medical Center Utrecht, Utrecht, the Netherlands., Neijts R; Oncode Institute, Hubrecht Institute-KNAW, University Medical Center Utrecht, Utrecht, the Netherlands., de Laat W; Oncode Institute, Hubrecht Institute-KNAW, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
FEBS letters [FEBS Lett] 2020 Nov; Vol. 594 (21), pp. 3439-3449. Date of Electronic Publication: 2020 Nov 03.
Autor:
Vermeulen C; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Allahyar A; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Bouwman BAM; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Krijger PHL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Geeven G; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Valdes-Quezada C; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Renkens I; Oncode Institute, Center for Molecular Medicine, University Medical Center, Utrecht University, Utrecht, the Netherlands., Straver R; Oncode Institute, Center for Molecular Medicine, University Medical Center, Utrecht University, Utrecht, the Netherlands., Kloosterman WP; Oncode Institute, Center for Molecular Medicine, University Medical Center, Utrecht University, Utrecht, the Netherlands., de Ridder J; Oncode Institute, Center for Molecular Medicine, University Medical Center, Utrecht University, Utrecht, the Netherlands. j.deridder-4@umcutrecht.nl., de Laat W; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. w.delaat@hubrecht.eu.
Publikováno v:
Nature protocols [Nat Protoc] 2020 Feb; Vol. 15 (2), pp. 364-397. Date of Electronic Publication: 2020 Jan 13.